Company Quick10K Filing
Oxbridge RE Holdings
Price0.89 EPS-0
Shares6 P/E-14
MCap5 P/FCF-1
Net Debt-8 EBIT-0
TEV-3 TEV/EBIT8
TTM 2019-09-30, in MM, except price, ratios
10-Q 2020-06-30 Filed 2020-08-10
10-Q 2020-03-31 Filed 2020-05-14
10-K 2019-12-31 Filed 2020-03-23
10-Q 2019-09-30 Filed 2019-11-04
10-Q 2019-06-30 Filed 2019-08-01
10-Q 2019-03-31 Filed 2019-05-14
10-K 2018-12-31 Filed 2019-03-19
10-Q 2018-09-30 Filed 2018-11-13
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-03-13
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-13
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-03-17
10-Q 2015-09-30 Filed 2015-11-12
10-Q 2015-06-30 Filed 2015-08-12
10-Q 2015-03-31 Filed 2015-05-14
10-K 2014-12-31 Filed 2015-03-18
10-Q 2014-09-30 Filed 2014-11-10
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-13
8-K 2020-08-10 Earnings, Exhibits
8-K 2020-06-18
8-K 2020-05-19
8-K 2020-05-14
8-K 2020-04-30
8-K 2020-03-23
8-K 2020-02-20
8-K 2019-12-02
8-K 2019-11-04
8-K 2019-08-01
8-K 2019-05-14
8-K 2019-05-10
8-K 2019-03-21
8-K 2019-03-19
8-K 2018-11-16
8-K 2018-11-13
8-K 2018-08-14
8-K 2018-05-11
8-K 2017-12-30

OXBR 10Q Quarterly Report

EX-31.1 oxbr_ex311.htm
EX-31.2 oxbr_ex312.htm
EX-32.2 oxbr_ex32.htm

Oxbridge RE Holdings Earnings 2020-06-30

Balance SheetIncome StatementCash Flow
655239261302014201620182020
Assets, Equity
25155-5-15-252014201620182020
Rev, G Profit, Net Income
3020100-10-202014201620182020
Ops, Inv, Fin

10-Q 1 oxbr_10q.htm QUARTERLY REPORT oxbr_10q
 

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
(Mark One)
 
[X] 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended June 30, 2020
 
[ ] 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from __________ to __________
 
Commission File Number: 1-36346
 
OXBRIDGE RE HOLDINGS LIMITED
(Exact name of registrant as specified in its charter)
 
 Cayman Islands
 98-1150254
 (State or other jurisdiction of incorporation or organization)
 (I.R.S. Employer Identification No.)
 
 Suite 20142 Edward Street, GeorgetownP.O. Box 469 Grand Cayman, Cayman Islands
 KY1-9006
 (Address of principal executive offices)
 (Zip Code)
 
  
Registrant’s telephone number, including area code: (345) 749-7570
 
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
 
Yes    X     No           
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
 
Yes    X     No           
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer                                            
 
 
Accelerated filer                                        
 
Non-accelerated filer 
 
Smaller reporting company                                                        X
 
Emerging growth company
 
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ______
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
 
Yes      No   X
 
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
 
As of August 10, 2020; 5,733,587 ordinary shares, par value $0.001 per share, were outstanding.
 

 
 
 
OXBRIDGE RE HOLDINGS LIMITED
 
INDEX
 
 
Page
 
 
 
Financial Statements
 3
 
 
 
 
3
 
 
 
 
4
 
 
 
 
5
 
 
 
 
6
 
 
8
 
 
Notes to the Consolidated Financial Statements (unaudited) 
9
 
 
 
Management’s Discussion and Analysis of Financial Condition and Results of Operations
22
 
 
Quantitative and Qualitative Disclosures About Market Risk 
30
 
 
 
Controls and Procedures 
30
 
 
 
 
 
 
Legal Proceedings 
31
 
 
 
Risk Factors 
31
 
 
 
Unregistered Sales of Equity Securities and Use of Proceeds 
31
 
 
 
Defaults Upon Senior Securities 
31
 
 
 
Mine Safety Disclosures 
31
 
 
 
Other Information 
31
 
 
 
Exhibits 
31
 
 
 
 
Signatures 
32
 
 
 
 
 
 
 
 
PART I - FINANCIAL INFORMATION
 
Item 1. Financial Statements
 
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
 
Consolidated Balance Sheets
(expressed in thousands of U.S. Dollars, except per share and share amounts)
 
 
 
 
 
At June 30, 2020
 
 
At December 31, 2019
 
 
 
(Unaudited)
 
 
 
 
Assets
 
 
 
 
 
 
Equity securities, at fair value (cost : $1,297 and $715 respectively)
 $949 
  692 
Cash and cash equivalents
  5,567 
  5,962 
Restricted cash and cash equivalents
  1,473 
  2,054 
Accrued interest and dividend receivable
  1 
  12 
Premiums receivable
  923 
  506 
Deferred policy acquisition costs
  100 
  48 
Operating lease right-of-use assets
  263 
  133 
Prepayment and other assets
  108 
  79 
Property and equipment, net
  19 
  9 
  Total assets
 $9,403 
  9,495 
 
    
    
Liabilities and Shareholders’ Equity
    
    
Liabilities:
    
    
Notes payable
 $216 
  600 
Unearned premiums reserve
  905 
  440 
Operating lease liabilities
  263 
  133 
Accounts payable and other liabilities
  159 
  279 
  Total liabilities
  1,543 
  1,452 
 
    
    
Shareholders’ equity:
    
    
Ordinary share capital, (par value $0.001, 50,000,000 shares authorized; 5,733,587 shares issued and outstanding)
  6 
  6 
Additional paid-in capital
  32,278 
  32,262 
Accumulated Deficit
  (24,424)
  (24,225)
Total shareholders’ equity
  7,860 
  8,043 
Total liabilities and shareholders’ equity
 $9,403 
  9,495 
 
The accompanying Notes to Consolidated Financial Statements are an integral
part of the Consolidated Financial Statements.
 
 
3
 
 
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
  Consolidated Statements of Operations
(Unaudited)
(expressed in thousands of U.S. Dollars, except per share amounts)
 
 
 
 
Three Months Ended
 
 
Six Months Ended
 
 
 
 June 30,
 
 
 June 30,
 
 
 
2020
 
 
2019
 
 
2020
 
 
2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
 
 
 
 
 
 
 
 
 
 
 
 
Assumed premiums
 $864 
  1,116 
  864 
  1,116 
Change in unearned premiums reserve
  (729)
  (1,023)
  (464)
  (1,023)
 
    
    
    
    
Net premiums earned
  135 
  93 
  400 
  93 
Net investment and other income
  25 
  64 
  57 
  128 
         Net realized investment gains
  320 
  - 
  326 
  3 
         Change in fair value of equity securities
  2 
  (48)
  (324)
  3 
 
    
    
    
    
Total revenue
  482 
  109 
  459 
  227 
 
    
    
    
    
Expenses
    
    
    
    
Policy acquisition costs and underwriting expenses
  15 
  10 
  44 
  10 
General and administrative expenses
  282 
  280 
  528 
  544 
 
    
    
    
    
Total expenses
  297 
  290 
  572 
  554 
 
    
    
    
    
Income (Loss) before income attributable to noteholders
  185 
  (181)
  (113)
  (327)
 
    
    
    
    
Income attributable to noteholders
  (20)
  (24)
  (86)
  (24)
 
    
    
    
    
Net income (loss)
 $165 
  (205)
  (199)
  (351)
 
    
    
    
    
Earnings (Loss) per share
    
    
    
    
Basic and Diluted
 $0.03 
  (0.04)
  (0.03)
  (0.06)
 
    
    
    
    
Weighted-average shares outstanding
    
    
    
    
Basic and Diluted
  5,733,587 
  5,733,587 
  5,733,587 
  5,733,587 
 
    
    
    
    
 
    
    
    
    
Dividends paid per share
 $- 
  - 
  - 
  - 
 
    
    
    
    
 
The accompanying Notes to Consolidated Financial Statements are an integral
part of the Consolidated Financial Statements.
 
 
4
 

OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
  Consolidated Statements of Comprehensive Income (Loss)
(Unaudited)
(expressed in thousands of U.S. Dollars)
 
 
 
 
Three Months Ended
 
 
Six Months Ended
 
 
 
June 30,
 
 
June 30,
 
 
 
2020
 
 
2019
 
 
2020
 
 
2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
 $165 
  (205)
  (199)
  (351)
Other comprehensive loss:
    
    
    
    
Change in unrealized loss on investments:
    
    
    
    
Unrealized gain arising during the period
  - 
  - 
  - 
  1 
Reclassification adjustment for net realized investment gains included in net loss
  - 
  - 
  - 
  (3)
 
    
    
    
    
Net change in unrealized loss
  - 
  - 
  - 
  (2)
 
    
    
    
    
Total other comprehensive loss
  - 
  - 
  - 
  (2)
 
    
    
    
    
Comprehensive income (loss)
 $165 
  (205)
  (199)
  (353)
 
The accompanying Notes to Consolidated Financial Statements are an integral
part of the Consolidated Financial Statements.
 
 
5
 
 
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
  Consolidated Statements of Cash Flows
(Unaudited)
(expressed in thousands of U.S. Dollars)
 
 
 
Six Months Ended
 
 
 
June 30,
 
 
 
2020
 
 
2019
 
Operating activities
 
 
 
 
 
 
Net loss
 $(199)
  (351)
Adjustments to reconcile net loss to net cash used in operating activities:
    
    
Stock-based compensation
  16 
  18 
Depreciation and amortization
  3 
  5 
Net realized investment gains
  (326)
  (3)
       Change in fair value of equity securities
  324 
  (3)
Change in operating assets and liabilities:
    
    
Accrued interest and dividend receivable
  11 
  6 
Premiums receivable
  (417)
  (993)
Deferred policy acquisition costs
  (52)
  (113)
Prepayment and other assets
  (29)
  (49)
Reserve for losses and loss adjustment expenses
  - 
  (4,001)
Unearned premiums reserve
  465 
  1,023 
Accounts payable and other liabilities
  (120)
  (5)
 
    
    
Net cash used in operating activities
 $(324)
  (4,466)
 
    
    
Investing activities
    
    
Purchase of equity securities
  (2,390)
  (402)
Proceeds from sale of equity securities
  2,135 
  - 
Proceeds from sale of fixed-maturity securities
  - 
  994 
Purchase of property and equipment
  (13)
  - 
 
    
    
Net cash (used in)/provided by investing activities
 $(268)
  592 
 
    
    
Financing activities
    
    
Proceeds on issuance of notes
  216 
  600 
Redemption of notes
  (600)
  - 
 
    
    
Net cash (used in)/provided by financing activities
 $(384)
  600 
 
    
    
 
 (continued)
 
 
 
6
 
 
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
 Consolidated Statements of Cash Flows, continued
(Unaudited)
(expressed in thousands of U.S. Dollars)
 
 
 
Six Months Ended
 
 
 
June 30,
 
 
 
2020
 
 
2019
 
 
 
 
 
 
 
 
Cash and cash equivalents, and restricted cash and cash equivalents:
 
 
 
 
 
 
Net change during the period
  (976)
  (3,274)
Balance, beginning of period
  8,016 
  11,299 
 
    
    
Balance, end of period
 $7,040 
  8,025 
 
    
    
Supplemental disclosure of cash flow information
    
    
Interest paid
  - 
  - 
Income taxes paid
  - 
  - 
 
    
    
Non-cash transaction activities
    
    
Net change in unrealized loss on securities available for sale
  - 
  (2)
Operating lease right-of-use assets
  169 
  155 
Operating lease liability
  169 
  149 
 
    
    
 
The accompanying Notes to Consolidated Financial Statements are an integral
part of the Consolidated Financial Statements.
 
 
7
 
 
OXBRIDGE RE HOLDINGS LIMITED AND SUBSIDIARIES
Consolidated Statements of Changes in Shareholders’ Equity (unaudited)
 Three and Six Months Ended June 30, 2020 and 2019
(expressed in thousands of U.S. Dollars, except share amounts)
 
 
 
Ordinary Share Capital
 
 
 
 
 
 
 
 
 
 
 
Shares
 
 
Amount
 
 
Additional
Paid-in Capital
 
 
Accumulated
Deficit
 
 
Accumulated Other
Comprehensive Income (Loss)
 
 
Total Shareholders'
Equity
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance at December 31, 2018
  5,733,587 
  6 
  32,226 
  (23,920)
  2 
  8,314 
Net loss for the period
  - 
  - 
  - 
  (146)
  - 
  (146)
Stock-based compensation
  - 
  - 
  9 
  - 
  - 
  9 
Total other comprehensive loss
  - 
  - 
  - 
  - 
  (2)
  (2)
Balance at March 31, 2019
  5,733,587 
  6 
  32,235 
  (24,066)
  - 
  8,175 
Net loss for the period
  - 
  - 
  - 
  (205)
  - 
  (205)
Stock-based compensation
  - 
  - 
  9 
  - 
  - 
  9 
Balance at June 30, 2019
  5,733,587 
  6 
  32,244 
  (24,271)
  - 
  7,979 
 
    
    
    
    
    
    
 
    
    
    
    
    
    
Balance at December 31, 2019
  5,733,587 
  6 
  32,262 
  (24,225)
  - 
  8,043 
Net loss for the period
  - 
  - 
  - 
  (364)
  - 
  (364)
Stock-based compensation
  - 
  - 
  8 
  - 
  - 
  8 
Balance at March 31, 2020
  5,733,587 
  6 
  32,270 
  (24,589)
  - 
  7,687 
Net income for the period
  - 
  - 
  - 
  165 
  - 
  165 
Stock-based compensation
  - 
  - 
  8 
  - 
  - 
  8 
Balance at June 30, 2020
  5,733,587 
  6 
  32,278 
  (24,424)
  - 
  7,860 
 
The accompanying Notes to Consolidated Financial Statements are an integral
part of the Consolidated Financial Statements.
 
 
8
 
  
1.
ORGANIZATION AND BASIS OF PRESENTATION
 
(a)
Organization
 
Oxbridge Re Holdings Limited (the “Company”) was incorporated as an exempted company on April 4, 2013 under the laws of the Cayman Islands. Oxbridge Re Holdings Limited owns 100% of the equity interest in Oxbridge Reinsurance Limited, an exempted entity incorporated on April 23, 2013 under the laws of the Cayman Islands and for which a Class “C” Insurer’s license was granted on April 29, 2013 under the provisions of the Cayman Islands Insurance Law. Oxbridge Re Holdings Limited also owns 100% of the equity interest in Oxbridge Re NS, an entity incorporated as an exempted company on December 22, 2017 under the laws of the Cayman Islands to function as a reinsurance sidecar facility and to increase the underwriting capacity of Oxbridge Reinsurance Limited. The Company, through its subsidiaries (collectively “Oxbridge Re”) provides collateralized reinsurance in the property catastrophe market and invests in various insurance-linked securities. The Company operates as a single business segment through its wholly-owned subsidiaries. The Company’s headquarters and principal executive offices are located at Suite 201, 42 Edward Street, Georgetown, Grand Cayman, Cayman Islands, and have their registered offices at P.O. Box 309, Ugland House, Grand Cayman, Cayman Islands.
 
The Company’s ordinary shares and warrants are listed on The NASDAQ Capital Market under the symbols “OXBR” and “OXBRW,” respectively.
 
(b)
Basis of Presentation and Consolidation
 
The accompanying unaudited, consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information, and the Securities and Exchange Commission (“SEC”) rules for interim financial reporting. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with GAAP have been omitted pursuant to such rules and regulations. However, in the opinion of management, the accompanying interim consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the Company’s consolidated financial position as of June 30, 2020 and the consolidated results of operations and cash flows for the periods presented. The consolidated results of operations for interim periods are not necessarily indicative of the results of operations to be expected for any subsequent interim period or for the fiscal year ended December 31, 2020. The accompanying unaudited consolidated financial statements and notes thereto should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2019 included in the Company’s Form 10-K, which was filed with the SEC on March 23, 2020.
 
In preparing the interim unaudited consolidated financial statements, management was required to make certain estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures at the financial reporting date and throughout the periods being reported upon. Certain of the estimates result from judgments that can be subjective and complex and consequently actual results may differ from these estimates, which would be reflected in future periods.
 
Material estimates that are particularly susceptible to significant change in the near-term relate to the determination of the reserve for losses and loss adjustment expenses, which include amounts estimated for claims incurred but not yet reported. The Company uses various assumptions and actuarial data it believes to be reasonable under the circumstances to make these estimates. In addition, accounting policies specific to valuation of investments and assessment of other-than-temporary impairment (“OTTI”) involve significant judgments and estimates material to the Company’s consolidated financial statements. Although considerable variability is likely to be inherent in these estimates, management believes that any amounts provided are reasonable. These estimates are continually reviewed and adjusted if necessary. Such adjustments are reflected in current operations.
 
The Company consolidates in these consolidated financial statements the results of operations and financial position of all voting interest entities (“VOE”) in which the Company has a controlling financial interest and all variable interest entities (“VIE”) in which the Company is considered to be the primary beneficiary. The consolidation assessment, including the determination as to whether an entity qualifies as a VIE or VOE, depends on the facts and circumstances surrounding each entity.
 
All significant intercompany balances and transactions have been eliminated.
 
 
9
 
 
2.
SIGNIFICANT ACCOUNTING POLICIES
 
Cash and cash equivalents: Cash and cash equivalents are comprised of cash and short- term investments with original maturities of three months or less.
 
Restricted cash and cash equivalents: Restricted cash and cash equivalents represent funds held in accordance with the Company’s trust agreements with ceding insurers and trustees, which requires the Company to maintain collateral with a market value greater than or equal to the limit of liability, less unpaid premium.
 
Investments: The Company from time to time invests in fixed-maturity securities and equity securities, and for which its fixed-maturity securities are classified as available-for-sale. The Company’s available for sale investments are carried at fair value with changes in fair value included as a separate component of accumulated other comprehensive income in shareholders’ equity. For the Company’s investment in equity securities, the changes in fair value are recorded within the consolidated statements of operations.
 
Unrealized gains or losses are determined by comparing the fair market value of the securities with their cost or amortized cost. Realized gains and losses on investments are recorded on the trade date and are included in the consolidated statements of operations. The cost of securities sold is based on the specified identification method. Investment income is recognized as earned and discounts or premiums arising from the purchase of debt securities are recognized in investment income using the interest method over the remaining term of the security.
 
The Company reviews fixed-maturity securities, if any, for other-than-temporary impairment ("OTTI") on a quarterly basis and more frequently when economic or market conditions warrant such review. When the fair value of any investment is lower than its cost, an assessment is made to see whether the decline is temporary or other-than-temporary. If the decline is determined to be other-than-temporary the investment is written down to fair value and an impairment charge is recognized in operations in the period in which the Company makes such determination. For a fixed-maturity security that the Company does not intend to sell nor is it more likely than not that the Company will be required to sell before recovery of its amortized cost, only the credit loss component is recognized in operations, while impairment related to all other factors is recognized in other comprehensive income. The Company considers various factors in determining whether an individual security is other-than-temporarily impaired.

Fair value measurement: GAAP establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under GAAP are as follows:
 
Level 1
Inputs that reflect unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date;
 
 
Level 2
Inputs other than quoted prices that are observable for the asset or liability either directly or indirectly, including inputs in markets that are not considered to be active; and
 
 
Level 3
Inputs that are unobservable.
 
Inputs are used in applying the various valuation techniques and broadly refer to the assumptions that market participants use to make valuation decisions, including assumptions about risk. For fixed maturity securities, inputs may include price information, volatility statistics, specific and broad credit data, liquidity statistics, broker quotes for similar securities and other factors. The fair value of investments in stocks and exchange-traded funds is based on the last traded price. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. However, the determination of what constitutes “observable” requires significant judgment by the Company’s investment custodians. The investment custodians consider observable data to be market data which is readily available, regularly distributed or updated, reliable and verifiable, not proprietary, and provided by independent sources that are actively involved in the relevant markets. The categorization of a financial instrument within the hierarchy is based upon the pricing transparency of the instrument.
 
 
10
 
 
2. 
SIGNIFICANT ACCOUNTING POLICIES (continued)
 
Derivative Financial Instruments: The Company, from time to time, may enter into underwriting contracts such as industry loss warranty contracts (“ILW”) that are treated as derivatives for GAAP purposes. GAAP requires that an entity recognize all derivatives in the consolidated balance sheet at fair value. It also requires that unrealized gains and losses resulting from changes in fair value be included in operations or comprehensive income (loss). The Company did not have any derivative financial assets nor derivative financial liabilities at June 30, 2020 or December 31, 2019.
 
 
Deferred policy acquisition costs (“DAC”): Policy acquisition costs consist of brokerage fees, federal excise taxes and other costs related directly to the successful acquisition of new or renewal insurance contracts and are deferred and amortized over the terms of the reinsurance agreements to which they relate. The Company evaluates the recoverability of DAC by determining if the sum of future earned premiums and anticipated investment income is greater than the expected future claims and expenses. If a loss is probable on the unexpired portion of policies in force, a premium deficiency loss is recognized. At June 30, 2020, the DAC was considered fully recoverable and no premium deficiency loss was recorded.
  
Property and equipment:  Property and equipment are recorded at cost when acquired. Property and equipment are comprised of motor vehicles, furniture and fixtures, computer equipment and leasehold improvements and are depreciated and amortized, using the straight-line method, over their estimated useful lives, which are five years for furniture and fixtures and computer equipment and four years for motor vehicles. Leasehold improvements are amortized over the lesser of the estimated useful lives of the assets or remaining lease term. The Company periodically reviews property and equipment that have finite lives, and that are not held for sale, for impairment by comparing the carrying value of the assets to their estimated future undiscounted cash flows. For the three-month and six-month periods ended June 30, 2020 and 2019, there were no impairments in property and equipment.
 
Allowance for uncollectible receivables: Management evaluates credit quality by evaluating the exposure to individual counterparties; where warranted management also considers the credit rating or financial position, operating results and/or payment history of the counterparty. Management establishes an allowance for amounts for which collection is considered doubtful. Adjustments to previous assessments are recognized as income in the year in which they are determined. At June 30, 2020, no receivables were determined to be overdue or impaired and, accordingly, no allowance for uncollectible receivables has been established.
 
Reserves for losses and loss adjustment expenses: The Company determines its reserves for losses and loss adjustment expenses on the basis of the claims reported by the Company’s ceding insurers and for losses incurred but not reported (“IBNR”), management uses the assistance of an independent actuary. The reserves for losses and loss adjustment expenses represent management’s best estimate of the ultimate settlement costs of all losses and loss adjustment expenses. Management believes that the amounts are adequate; however, the inherent impossibility of predicting future events with precision, results in uncertainty as to the amount which will ultimately be required for the settlement of losses and loss expenses, and the differences could be material. Adjustments are reflected in the consolidated statements of operations in the period in which they are determined.
 
Loss experience refund payable: Certain contracts may include retrospective provisions that adjust premiums or result in profit commissions in the event losses are minimal or zero. In accordance with GAAP, the Company will recognize a liability in the period in which the absence of loss experience obligates the Company to pay cash or other consideration under the contracts. On the contrary, the Company will derecognize such liability in the period in which a loss experience arises. Such adjustments to the liability, which accrue throughout the contract terms, will reduce the liability should a catastrophic loss event covered by the Company occur.
 
Premiums assumed: The Company records premiums assumed, net of loss experience refunds, as earned pro-rata over the terms of the reinsurance agreements, or period of risk, where applicable, and the unearned portion at the consolidated balance sheet date is recorded as unearned premiums reserve. A reserve is made for estimated premium deficiencies to the extent that estimated losses and loss adjustment expenses exceed related unearned premiums. Investment income is not considered in determining whether or not a deficiency exists.
 
Subsequent adjustments of premiums assumed, based on reports of actual premium by the ceding companies, or revisions in estimates of ultimate premium, are recorded in the period in which they are determined. Such adjustments are generally determined after the associated risk periods have expired, in which case the premium adjustments are fully earned when assumed.
 
 
11
 
 
2. 
SIGNIFICANT ACCOUNTING POLICIES (continued)
 
Certain contracts may allow for reinstatement premiums in the event of a full limit loss prior to the expiration of the contract. A reinstatement premium is not due until there is a full limit loss event and therefore, in accordance with GAAP, the Company records a reinstatement premium as written only in the event that the reinsured incurs a full limit loss on the contract and the contract allows for a reinstatement of coverage upon payment of an additional premium. For catastrophe contracts which contractually require the payment of a reinstatement premium equal to or greater than the original premium upon the occurrence of a full limit loss, the reinstatement premiums are earned over the original contract period. Reinstatement premiums that are contractually calculated on a pro-rata basis of the original premiums are earned over the remaining coverage period.
 
Unearned Premiums Ceded: The Company reduces the risk of future losses on business assumed by reinsuring certain risks and exposures with other reinsurers (retrocessionaires). The Company remains liable to the extent that any retrocessionaire fails to meet its obligations and to the extent that the Company does not hold sufficient security for their unpaid obligations.
 
Ceded premiums are written during the period in which the risk incept and are expensed over the contract period in proportion to the period of protection. Unearned premiums ceded consist of the unexpired portion of the reinsurance obtained.
 
Uncertain income tax positions: The authoritative GAAP guidance on accounting for, and disclosure of, uncertainty in income tax positions requires the Company to determine whether an income tax position of the Company is more likely than not to be sustained upon examination by the relevant tax authority, including resolution of any related appeals or litigation processes, based on the technical merits of the position. For income tax positions meeting the more likely than not threshold, the tax amount recognized in the consolidated financial statements, if any, is reduced by the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement with the relevant taxing authority. The application of this authoritative guidance has had no effect on the Company’s consolidated financial statements because the Company had no uncertain tax positions at June 30, 2020.
 
Earnings (Loss) Per Share: Basic earnings(loss) per share has been computed on the basis of the weighted-average number of ordinary shares outstanding during the periods presented. Diluted earnings(loss) per share is computed based on the weighted-average number of ordinary shares outstanding and reflects the assumed exercise or conversion of diluted securities, such as stock options and warrants, computed using the treasury stock method.
 
Stock-Based Compensation: The Company accounts for stock-based compensation under the fair value recognition provisions of GAAP which requires the measurement and recognition of compensation for all stock-based awards made to employees and directors, including stock options and restricted stock issuances based on estimated fair values. The Company measures compensation for restricted stock based on the price of the Company’s ordinary shares at the grant date. Determining the fair value of stock options at the grant date requires significant estimation and judgment. The Company uses an option-pricing model (Black-Scholes option pricing model) to assist in the calculation of fair value for stock options. The Company's shares have not been publicly traded for a sufficient length of time to solely use the Company's performance to reasonably estimate the expected volatility. Therefore, when estimating the expected volatility, the Company takes into consideration the historical volatility of similar entities. The Company considers factors such as an entity's industry, stage of life cycle, size and financial leverage when selecting similar entities. The Company may use a sample peer group of companies in the reinsurance industry and/or the Company’s own historical volatility in determining the expected volatility. Additionally, the Company uses the full life of the options, ten years, as the estimated term of the options, and has assumed no forfeitures during the life of the options.
 
The Company uses the straight-line attribution method for all grants that include only a service condition. Compensation expense related to all awards is included in general and administrative expenses. 
 
Pending Accounting Updates:
 
  Accounting Standards Update No. 2016-13. In June 2016, the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurements of Credit Losses on Financial Instruments” (“ASU 2016-13”). ASU 2016-13 amends the guidance on reporting credits losses and affects loans, debt securities, trade receivables, reinsurance recoverable and other financial assets that have the contractual right to receive cash. The amendments are effective for annual periods beginning after December 15, 2022 (as amended), and interim periods within those annual periods. The Company is in the process of evaluating the impact of the requirements of ASU 2016-13 on the Company’s consolidated financial statements.
 
 
12
 
 
 
 
Segment Information: Under GAAP, operating segments are based on the internal information that management uses for allocating resources and assessing performance as the source of the Company’s reportable segments. The Company manages its business on the basis of one operating segment, Property and Casualty Reinsurance, in accordance with the qualitative and quantitative criteria established under GAAP.
 
Reclassifications: Any reclassifications of prior period amounts have been made to conform to the current period presentation.
 
 
3.
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS
 
 
 
At June 30,
 
 
At December 31,
 
 
 
2020
 
 
2019
 
 
 
(in thousands)
 
 
 
 
 
 
 
 
Cash on deposit
 $3,020 
 $3,456 
Cash held with custodians
  2,547 
  2,506 
Restricted cash held in trust
  1,473 
  2,054 
 
    
    
Total
 $7,040 
 $8,016 
 
 
Cash and cash equivalents are held by large and reputable counterparties in the United States of America and in the Cayman Islands. Restricted cash held in trust is custodied with Truist Bank and is held in accordance with the Company’s trust agreements with the ceding insurers and trustees, which require that the Company provide collateral having a market value greater than or equal to the limit of liability, less unpaid premium.
 
 
4. 
INVESTMENTS
 
The Company from time to time invests in fixed-maturity securities and equity securities, with its fixed-maturity securities classified as available-for-sale. At June 30, 2020 and December 31, 2019, the Company did not hold any available-for-sale securities.
 
Proceeds received, and the gross realized gains and losses from sales of available-for-sale fixed-maturity securities, and equity securities, for the three and six months ended June 30, 2020 and six months ended June 30, 2019 were as follows:
 
 
 
 Gross proceeds from sales
 
 
 Gross Realized Gains
 
 
 Gross Realized Losses
 
 
 
  ($ in thousands)
 
 Three Months Ended June 30, 2020
 
 
 
 
 
 
 
 
 
 Equity securities
 $1,889 
 $320 
 $- 
 
    
    
    
 Six Months Ended June 30, 2020
    
    
    
 Equity securities
 $2,135 
 $326 
 $- 
  
    
    
    
   Six Months Ended June 30, 2019
    
    
    
   Available-for-sale fixed-maturity securities
 $994 
 $3 
 $- 
 
 
13

 
4. 
INVESTMENTS (continued)
 
Assets Measured at Estimated Fair Value on a Recurring Basis
 
The following table presents information about the Company’s financial assets measured at estimated fair value on a recurring basis that is reflected in the consolidated balance sheets at carrying value. The table indicates the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value as of June 30, 2020 and December 31, 2019:
 
 
  Fair Value Measurements Using      
 
 
(Level 1)
 
 
(Level 2)
 
 
(Level 3)
 
 
Total
 
As of June 30, 2020
 
($ in thousands)
 
Financial Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 $5,567 
 $- 
 $- 
 $5,567 
 
    
    
    
    
Restricted cash and cash equivalents
 $1,473 
 $- 
 $- 
 $1,473 
 
    
    
    
    
Total equity securities
 $949 
 $- 
 $- 
 $949 
 
    
    
    
    
Total
 $7,989 
 $- 
 $- 
 $7,989 
 
 
 
 
Fair Value Measurements Using      
 
 
 
(Level 1)
 
 
(Level 2)
 
 
(Level 3)
 
 
Total
 
As of December 31, 2019
 
($ in thousands)
 
Financial Assets:
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 $5,962 
 $- 
 $- 
 $5,962 
 
    
    
    
    
Restricted cash and cash equivalents
 $2,054 
 $- 
 $- 
 $2,054 
 
    
    
    
    
Total equity securities
 $692 
 $- 
 $- 
 $692 
 
    
    
    
    
Total
 $8,708 
 $- 
 $- 
 $8,708 
 
There were no transfers between Levels 1, 2 and 3 during the three and six months ended June 30, 2020 and 2019.
 
5.  TAXATION
 
Under current Cayman Islands law, no corporate entity, including the Company and the subsidiaries, is obligated to pay taxes in the Cayman Islands on either income or capital gains. The Company and its subsidiaries have an undertaking from the Governor-in-Cabinet of the Cayman Islands, pursuant to the provisions of the Tax Concessions Law, as amended, that, in the event that the Cayman Islands enacts any legislation that imposes tax on profits, income, gains or appreciations, or any tax in the nature of estate duty or inheritance tax, such tax will not be applicable to the Company and its subsidiaries or their operations, or to the ordinary shares or related obligations, until April 23, 2033 and May 17, 2033, respectively.
 
The Company and its subsidiaries intend to conduct substantially all of their operations in the Cayman Islands in a manner such that they will not be engaged in a trade or business in the U.S. However, because there is no definitive authority regarding activities that constitute being engaged in a trade or business in the U.S. for federal income tax purposes, the Company cannot assure that the U.S. Internal Revenue Service will not contend, perhaps successfully, that the Company or its subsidiary is engaged in a trade or business in the U.S. A foreign corporation deemed to be so engaged would be subject to U.S. federal income tax, as well as branch profits tax, on its income that is treated as effectively connected with the conduct of that trade or business unless the corporation is entitled to relief under an applicable tax treaty.
 
 
14
 
 
 
6.            
VARIABLE INTEREST ENTITIES
 
Oxbridge Re NS. On December 22, 2017, the Company established Oxbridge Re NS, a Cayman domiciled and licensed special purpose insurer, formed to provide additional collateralized capacity to support Oxbridge Reinsurance Limited’s reinsurance business. In respect of the debt issued by Oxbridge Re NS to investors, Oxbridge Re NS has entered into retrocession agreements with Oxbridge Reinsurance Limited on June 1, 2020 and June 1, 2019. Under these agreements, Oxbridge Re NS receives a quota share of Oxbridge Reinsurance Limited’s catastrophe business. Oxbridge Re NS is a non-rated insurer and the risks have been fully collateralized by way of funds held in trust for the benefit of Oxbridge Reinsurance Limited. Oxbridge Re NS is able to provide investors with access to diversified natural catastrophe risk backed by the distribution, underwriting, analysis and research expertise of Oxbridge Re.
 
The Company has determined that Oxbridge Re NS meets the definition of a VIE as it does not have sufficient equity capital to finance its activities. The Company concluded that it is the primary beneficiary and has consolidated the subsidiary upon its formation, as it owns 100% of the voting shares, 100% of the issued share capital and has a significant financial interest and the power to control the activities of Oxbridge Re NS that most significantly impacts its economic performance. The Company has no other obligation to provide financial support to Oxbridge Re NS. Neither the creditors nor beneficial interest holders of Oxbridge Re NS have recourse to the Company’s general credit.
 
Upon issuance of a series of participating notes by Oxbridge Re NS, all of the proceeds from the issuance are deposited into collateral accounts, to fund any potential obligation under the reinsurance agreements entered into with Oxbridge Reinsurance Limited underlying such series of notes. The outstanding principal amount of each series of notes generally is expected to be returned to holders of such notes upon the expiration of the risk period underlying such notes, unless an event occurs which causes a loss under the applicable series of notes, in which case the amount returned is expected to be reduced by such noteholder's pro rata share of such loss, as specified in the applicable governing documents of such notes.

In addition, holders of such notes are generally entitled to interest payments, payable annually, as determined by the applicable governing documents of each series of notes. Oxbridge Re Holdings Limited receives an origination and structuring fee in connection with the formation, operation and management of Oxbridge Re NS.
 
Notes Payable to Series 2020-1 noteholders
 
    Oxbridge Re NS entered into a retrocession agreement with Oxbridge Reinsurance Ltd on June 1, 2020 and issued $216 thousand of participating notes which provides quota share support for Oxbridge Re’s global property catastrophe excess of loss reinsurance business. The participating notes have been assigned Series 2020-1 and are due to mature on June 1, 2023. None of the participating notes were redeemed during the period ending June 30, 2020.
 
    The income from Oxbridge Re NS operations that are attributable to the participating notes noteholders for the three and six month ended June 30, 2020 was $8,600 and are included within accounts payable and other liabilities as at June 30, 2020.
 
Notes Payable to Series 2019-1 noteholders
 
    Oxbridge Re NS entered into a retrocession agreement with Oxbridge Reinsurance Ltd on June 1, 2019 and issued $600 thousand of participating notes which provides quota share support for Oxbridge Re’s global property catastrophe excess of loss reinsurance business. The participating notes were assigned Series 2019-1 and were due to mature on June 1, 2022. However, the participating notes were all redeemed during the period ending June 30, 2020.
 
    The income from Oxbridge Re NS operations that were attributable to the participating notes noteholders for the three months ended June 30, 2020 and June 30, 2019 was $11,400 and $24,000 respectively. The income from Oxbridge Re NS operations that were attributable to the participating notes noteholders for the six months ended June 30, 2020 and June 30, 2019 was $77,700 and $24,000 respectively. The income attributable to the participating notes noteholders for the three and six-month periods ended June 30,2019 were included within accounts payable and other liabilities as at June 30, 2019.
 
 
15
 
 
7.  RESERVE FOR LOSSES AND LOSS ADJUSTMENT EXPENSES
 
The following table summarizes the Company’s loss and loss adjustment expenses (“LAE”) and the reserve for loss and LAE reserve movements for the three and six-month periods ending June 30, 2020 and 2019:
 
 
 
 
Three Months Ended
 
 
Six Months Ended
 
 
 
June 30,
 
 
June 30,
 
 
 
2020
 
 
2019
 
 
2020
 
 
2019
 
 
 
($ in thousands)
 
 
($ in thousands)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, beginning of period
 $- 
  107 
 $- 
  4,108 
Incurred related to:
    
    
    
    
     Current period
  - 
  - 
  - 
  - 
     Prior period
  - 
  - 
  - 
  - 
           Total incurred
  - 
  - 
  - 
  - 
Paid related to:
    
    
    
    
     Current period
  - 
  - 
  - 
  - 
     Prior period
  - 
  - 
  - 
  (4,001)
           Total paid
  - 
  - 
  - 
  (4,001)
Balance, end of period
 $- 
  107 
 $- 
  107 
 
The reserves for losses and LAE are comprised of case reserves (which are based on claims that have been reported) and IBNR reserves (which are based on losses that are believed to have occurred but for which claims have not yet been reported and include a provision for expected future development on existing case reserves). The Company uses the assistance of an independent actuary in the determination of IBNR and expected future development of existing case reserves.
 
The uncertainties inherent in the reserving process and potential delays by cedants and brokers in the reporting of loss information, together with the potential for unforeseen adverse developments, may result in the reserve for losses and LAE ultimately being significantly greater or less than the reserve provided at the end of any given reporting period. The degree of uncertainty is further increased when a significant loss event takes place near the end of a reporting period. Reserve for losses and LAE estimates are reviewed periodically on a contract by contract basis and updated as new information becomes known. Any resulting adjustments are reflected in income in the period in which they become known.
 
The Company’s reserving process is highly dependent on the timing of loss information received from its cedants and related brokers.
 
8.  EARNINGS (LOSS) PER SHARE
 
A summary of the numerator and denominator of the basic and diluted earnings(loss) per share is presented below (dollars in thousands except per share amounts):
 
 
 
Three Months Ended
 
 
Six Months Ended
 
 
 
 June 30,
 
 
 June 30,
 
 
 
2020
 
 
2019
 
 
2020
 
 
2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Numerator:
 
 
 
 
 
 
 
 
 
 
 
 
     Net earnings(loss)
 $165 
  (205)
 $(199)
  (351)
 
    
    
    
    
Denominator:
    
    
    
    
    Weighted average shares - basic
  5,733,587 
  5,733,587 
  5,733,587 
  5,733,587 
    Effect of dilutive securities - Stock options
  - 
  - 
  - 
  - 
    Shares issuable upon conversion of warrants
  - 
  - 
  - 
  - 
    Weighted average shares - diluted
  5,733,587 
  5,733,587 
  5,733,587 
  5,733,587 
Earnings (loss) per share - basic
 $0.03 
  (0.04)
 $(0.03)
  (0.06)
Earnings (loss) per share - diluted
 $0.03 
  (0.04)
 $(0.03)
  (0.06)
 
    
    
    
    
 
 
16
 
 
For the three-month period ended June 30, 2020, options to purchase 540,000 ordinary shares were anti-dilutive due to the sum of the proceeds, including unrecognized compensation expense, exceeded the average market price of the Company’s ordinary share during the period presented. For the three-month period ended June 30, 2019 and six-month periods ended June 30, 2020 and 2019, options to purchase 540,000 ordinary shares were anti-dilutive due to net loss during the periods presented.
 
For the three-month period ended June 30, 2020, 8,230,700 warrants to purchase an aggregate of 8,230,700 ordinary shares were anti-dilutive because the exercise price of $7.50 exceeded the average market price of the Company’s ordinary share during the periods presented. For the three-month period ended June 30, 2019 and six-month periods ended June 30, 2020 and 2019, 8,230,700 warrants to purchase an aggregate of 8,230,700 ordinary shares were anti-dilutive due to net loss during the periods presented.
 
    GAAP requires the Company to use the two-class method in computing basic loss per share since holders of the Company’s restricted stock have the right to share in dividends, if declared, equally with common stockholders. These participating securities effect the computation of both basic and diluted loss per share during periods of net loss.
 
9.       
SHAREHOLDERS’ EQUITY
 
On February 28, 2014, the Company’s Registration Statement on Form S-1, as amended, relating to the initial public offering of the Company’s units was declared effective by the SEC. The Registration Statement covered the offer and sale by the Company of 4,884,650 units, each consisting of one ordinary share and one warrant (“Unit”), which were sold to the public on March 26, 2014 at a price of $6.00 per Unit. The ordinary shares and warrants comprising the Units began separate trading on May 9, 2014. The ordinary shares and warrants are traded on the Nasdaq Capital Market under the symbols “OXBR” and “OXBRW,” respectively. One warrant may be exercised to acquire one ordinary share at an exercise price equal to $7.50 per share on or before March 26, 2024, as amended. At any time after September 26, 2014 and before the expiration of the warrants, the Company at its option may cancel the warrants in whole or in part, provided that the closing price per ordinary share has exceeded $9.38 for at least ten trading days within any period of twenty consecutive trading days, including the last trading day of the period.
 
The initial public offering resulted in aggregate gross proceeds to the Company of approximately $29.3 million (of which approximately $5 million related to the fair value proceeds on the warrants issued) and net proceeds of approximately $26.9 million after deducting underwriting commissions and offering expenses.
 
There were 8,230,700 warrants outstanding at June 30, 2020 and 2019. No warrants were exercised during the three and six-month periods ended June 30, 2020 and 2019.
 
As of June 30, 2020, none of the Company’s retained earnings were restricted from payment of dividends to the company’s shareholders. However, since most of the Company’s capital and retained earnings may be invested in its subsidiaries, a dividend from the subsidiaries would likely be required in order to fund a dividend to the Company’s shareholders and would require notification to the Cayman Islands Monetary Authority (“CIMA”).
 
Under Cayman Islands law, the use of additional paid-in capital is restricted, and the Company will not be allowed to pay dividends out of additional paid-in capital if such payments result in breaches of the prescribed and minimum capital requirement.
 
 
17
 
 
10.                         
SHARE-BASED COMPENSATION
 
The Company currently has outstanding stock-based awards granted under the 2014 Omnibus Incentive Plan (the “Plan”). Under the Plan, the Company has discretion to grant equity and cash incentive awards to eligible individuals, including the issuance of up to 1,000,000 of the Company’s ordinary shares. At June 30, 2020, there were 400,000 shares available for grant under the Plan.
 
Stock options
 
Stock options granted and outstanding under the Plan vests quarterly over four years and are exercisable over the contractual term of ten years.
 
A summary of the stock option activity for the three and six-month periods ended June 30, 2020 and 2019 is as follows:
 
 
 
 Number
of Options
 
 
 Weighted-Average
Exercise Price
 
 
 Weighted-Average
Remaining Contractual Term
 
 
  Aggregate Intrinsic Value
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at January 1, 2020
  540,000 
 $3.86 
       
       
Outstanding at March 31, 2020
  540,000 
 $3.86 
  7.1 years 
 $- 
Outstanding at June 30, 2020
  540,000 
 $3.86 
  6.9 years 
 $- 
Exercisable at June 30, 2020
  354,375 
 $4.78 
  6.1 years 
 $- 
 
    
    
    
    
 
    
    
    
    
Outstanding at January 1, 2019
  250,000 
 $6.01 
    
    
Granted
  290,000 
 $2.00 
    
    
Outstanding at March 31, 2019
  540,000 
 $3.86 
  8.1 years 
 $- 
Outstanding at June 30, 2019
  540,000 
 $3.86 
  7.9 years 
 $- 
Exercisable at June 30, 2019
  268,750 
 $5.47 
  6.3 years 
 $- 
 
    
    
    
    
 
Compensation expense recognized for the three-month periods ended June 30, 2020 and 2019 totaled $8,000 and $9,000 respectively and for the six month periods ended June 30, 2020 and 2019, totaled $16,000 and $18,000 respectively. Compensation expense is included in general and administrative expenses. At June 30, 2020 and 2019, there was approximately $70,000 and $103,000, respectively, of total unrecognized compensation expense related to non-vested stock options granted under the Plan. The Company expects to recognize the remaining compensation expense over a weighted-average period of twenty-four (24) months.
 
 
18
 
 
No options were granted during the three and six-month period ended June 30, 2020. During the six-month period ended June 30, 2019 the Company granted 290,000 options with fair value estimated on the date of grant using the following assumptions and the Black-Scholes option pricing model:
 
 
 
2019
 
 
 
 
 
Expected dividend yield
  0%
Expected volatility
  31%
Risk-free interest rate
  2.59%
Expected life (in years)
  10 
Per share grant date fair value of options issued
 $0.36 
 
At the time of the grant, the dividend yield was based on the Company’s history and expectation of dividend payouts at the time of the grant; expected volatility was based on volatility of similar companies’ common stock; the risk-free rate was based on the U.S. Treasury yield curve in effect and the expected life was based on the contractual life of the options.
 
 
Restricted Stock Awards
 
The Company may grant restricted stock awards to eligible individuals in connection with their service to the Company. The terms of the Company’s outstanding restricted stock grants may include service, performance and market-based conditions. The fair value of any awards with market-based conditions is determined using a Monte Carlo simulation method, which calculates many potential outcomes for an award and then establishes fair value based on the most likely outcome. The determination of fair value with respect to the awards with only performance or service-based conditions is based on the value of the Company’s stock on the grant date.
 
During the three and six-month periods ended June 30, 2020 and 2019, the Company did not grant any restricted stock. At June 30, 2020, there were no unvested restricted stock.
 
11.                       
NET WORTH FOR REGULATORY PURPOSES
 
The subsidiaries are subject to a minimum and prescribed capital requirement as established by CIMA. Under the terms of their respective licenses, Oxbridge Reinsurance Limited and Oxbridge Re NS are required to maintain a minimum and prescribed capital requirement of $500 in accordance with the relevant subsidiary’s approved business plan filed with CIMA.
 
At June 30, 2020, the Oxbridge Reinsurance Limited’s net worth of $1 million exceeded the minimum and prescribed capital requirement. For the three and six-month periods ended June 30, 2020, the Subsidiary’s net loss was approximately $257 thousand and $408 thousand respectively.
 
At June 30, 2020, the Oxbridge Re NS’ net worth of $137 thousand exceeded the minimum and prescribed capital requirement. For the three and six-month periods ended June 30, 2020, the Subsidiary’s net income was approximately $7 thousand and $32 thousand respectively.
 
The Subsidiaries are not required to prepare separate statutory financial statements for filing with CIMA, and there were no material differences between the Subsidiaries' GAAP capital, surplus and net income, and its statutory capital, surplus and net income as of June 30, 2020 or for the period then ended.
 
 
12.            
FAIR VALUE AND CERTAIN RISKS AND UNCERTAINTIES
 
Fair values
 
With the exception of balances in respect of insurance contracts (which are specifically excluded from fair value disclosures under GAAP) and investment securities and derivative instruments as disclosed in Note 4 and 5 of these consolidated financial statements, the carrying amounts of all other financial instruments, which consist of cash and cash equivalents, restricted cash and cash equivalents, accrued interest and dividends receivable, premiums receivable and other assets and accounts payable and other liabilities, approximate their fair values due to their short-term nature.
 
 
19
 
 
Concentration of underwriting risk
 
A substantial portion of the Company’s current reinsurance business ultimately relates to the risks of a limited number of entities; accordingly, the Company’s underwriting risks are not significantly diversified.
 
Concentrations of Credit and Counterparty Risk
 
The Company markets retrocessional and reinsurance policies worldwide through its brokers.  Credit risk exists to the extent that any of these brokers may be unable to fulfill their contractual obligations to the Company.  For example, the Company is required to pay amounts owed on claims under policies to brokers, and these brokers, in the Company. In some jurisdictions, if a broker fails to make such a payment, the Company might remain liable to the ceding company for the deficiency. In addition, in certain jurisdictions, when the ceding company pays premiums for these policies to brokers, these premiums are considered to have been paid and the ceding insurer is no longer liable to the Company for those amounts, whether or not the premiums have actually been received.
 
The Company remains liable for losses it incurs to the extent that any third-party reinsurer is unable or unwilling to make timely payments under reinsurance agreements.  The Company would also be liable in the event that its ceding companies were unable to collect amounts due from underlying third-party reinsurers.
 
The Company mitigates its concentrations of credit and counterparty risk by using reputable and several counterparties which decreases the likelihood of any significant concentration of credit risk with any one counterparty.
 
Market risk
 
Market risk exists to the extent that the values of the Company’s monetary assets fluctuate as a result of changes in market prices. Changes in market prices can arise from factors specific to individual securities or their respective issuers, or factors affecting all securities traded in a particular market. Relevant factors for the Company are both volatility and liquidity of specific securities and markets in which the Company holds investments. The Company has established investment guidelines that seek to mitigate significant exposure to market risk.
 
13. LEASES
 
We adopted ASU 2016-02, Leases on January 1, 2019, which resulted in the recognition of operating leases on the consolidated balance sheet in 2019 and forward. See Note 2 – Significant Accounting Policies for more information on the adoption of the ASU. Operating lease right-of-use assets and operating lease liabilities are disclosed as line in the consolidated balance sheet. We determine if a contract contains a lease at inception and recognize operating lease right-of-use assets and operating lease liabilities based on the present value of the future minimum lease payments at the commencement date. As our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. Lease agreements that have lease and non-lease components, are accounted for as a single lease component. Lease expense is recognized on a straight-line basis over the lease term.
 
The Company has two operating lease obligations namely for the Company’s office facilities located at Suite 201, 42 Edward Street Grand Cayman, Cayman Islands and residential space at Turnberry Villas in Grand Cayman, Cayman Islands. The office lease has a remaining lease term of approximately 44 months and includes an option to extend the lease. Under the terms of the lease, the Company also has the right to terminate the lease after thirty-six (36) months upon giving appropriate notice in writing to the Lessor. The residential lease has a remaining lease term of approximately 30 months.
 
The components of lease expense and other lease information as of and during the three and six-month period ended June 30, 2020 and 2019 are as follows:
 
 
 
For the Six-Month Period
 
 
For the Six-Month Period
 
(in thousands)
 
Ended June 30, 2020
 
 
Ended June 30, 2019
 
Operating Lease Cost (1)
 $39 
 $41 
 
    
    
Cash paid for amounts included in the measurement of lease liabilities
    
    
Operating cash flows from operating leases
 $48 
 $49 
 
    
    
(1) Includes short-term leases
    
    
 
 
20
 
 
(in thousands)
 
At June 30, 2020
 
 
At June 30, 2019
 
Operating lease right-of-use assets
 $263 
 $146 
 
    
    
Operating lease liabilities
 $263 
 $146 
 
    
    
Weighted-average remaining lease term - operating leases
 
3.10 years
 
 
4.67 years
 
 
    
    
Weighted-average discount rate - operating leases
  5.26%
  6.5%
 
Future minimum lease payments under non-cancellable leases as of June 30, 2020, reconciled to our discounted operating lease liability presented on the consolidated balance sheet are as follows:
 
(in thousands)
 
At June 30, 2020
 
 
At December 31, 2019
 
Remainder of 2020
 $48 
 $36 
2021
  96 
  36 
2022
  97 
  37 
2023
  40 
  37 
Thereafter
  6 
  6 
Total future minimum lease payments
 $287 
 $152 
 
    
    
Less imputed interest
  (24)
  (19)
Total operating lease liability
 $263 
  133 
 
14.            
RELATED PARTY TRANSACTIONS
 
    During the three and six-month periods ending June 30, 2020, Mr. Jay Madhu, a director and officer of the Company and its subsidiaries invested $68 thousand in Series 2020-1 participating notes, which is included within notes payable on the consolidated balance sheets.
 
 
    During the three and six-month periods ending June 30, 2019, Mr, Jay Madhu, a director and officer of the Company and its subsidiaries invested $50 thousand in Series 2019-1 participating notes, which were subsequently redeemed in June 2020.
 
15.            
SUBSEQUENT EVENTS
 
We evaluate all subsequent events and transactions for potential recognition or disclosure in our consolidated financial statements. There were no other events subsequent to June 30, 2020 for which disclosure was required.
 
 
21
 
 
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
 
SPECIAL NOTE ABOUT FORWARD-LOOKING STATEMENTS
 
Certain statements in this Quarterly Report on Form 10-Q, including in this Management’s Discussion and Analysis, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements generally are identified by the words “believe,” “project,” “predict,” “expect,” “anticipate,” “estimate,” “intend,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements is included in the section entitled “Risk Factors” contained in our Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 23, 2020. We undertake no obligation to publicly update or revise any forward -looking statements, whether as a result of new information, future events, or otherwise. Readers are cautioned not to place undue reliance on the forward -looking statements which speak only to the dates on which they were made.
 
GENERAL
 
The following is a discussion and analysis of our results of operations for the three and six-month periods ended June 30, 2020 and 2019 and our financial condition as of June 30, 2020 and December 31, 2019. The following discussion should be read in conjunction with our consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q and in our Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 23, 2020. References to “we,” “us,” “our,” “our company,” or “the Company” refer to Oxbridge Re Holdings Limited and its wholly-owned subsidiaries, Oxbridge Reinsurance Limited and Oxbridge Re NS, unless the context dictates otherwise.
 
Overview
 
We are a Cayman Islands specialty property and casualty reinsurer that provides reinsurance solutions through our reinsurance subsidiary, Oxbridge Reinsurance Limited. We organized a new subsidiary, Oxbridge Re NS, which was incorporated on December 22, 2017 to function as a reinsurance sidecar which increases the underwriting capacity of Oxbridge Reinsurance Limited. Oxbridge Re NS commenced operations on June 1, 2018 and issued participating notes to third party investors, the proceeds of which was utilized to collateralize Oxbridge Reinsurance Limited’s reinsurance obligations. We focus on underwriting fully-collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. We specialize in underwriting medium frequency, high severity risks, where we believe sufficient data exists to analyze effectively the risk/return profile of reinsurance contracts.
 
We underwrite reinsurance contracts on a selective and opportunistic basis as opportunities arise based on our goal of achieving favorable long-term returns on equity for our shareholders. Our goal is to achieve long-term growth in book value per share by writing business that generates attractive underwriting profits relative to the risk we bear. Unlike other insurance and reinsurance companies, we do not intend to pursue an aggressive investment strategy and instead will focus our business on underwriting profits rather than investment profits. However, we intend to complement our underwriting profits with investment profits on an opportunistic basis. Our primary business focus is on fully collateralized reinsurance contracts for property catastrophes, primarily in the Gulf Coast region of the United States, with an emphasis on Florida. Within that market and risk category, we attempt to select the most economically attractive opportunities across a variety of property and casualty insurers. As our capital base grows, however, we expect that we will consider further growth opportunities in other geographic areas and risk categories.
 
Our level of profitability is primarily determined by how adequately our premiums assumed and investment income cover our costs and expenses, which consist primarily of acquisition costs and other underwriting expenses, claim payments and general and administrative expenses. One factor leading to variation in our operational results is the timing and magnitude of any follow-on offerings we undertake (if any), as we are able to deploy new capital to collateralize new reinsurance treaties and consequently, earn additional premium revenue. In addition, our results of operations may be seasonal in that hurricanes and other tropical storms typically occur during the period from June 1 through November 30. Further, our results of operations may be subject to significant variations due to factors affecting the property and casualty insurance industry in general, which include competition, legislation, regulation, general economic conditions, judicial trends, and fluctuations in interest rates and other changes in the investment environment.
 
 
22
 
 
Because we employ an opportunistic underwriting and investment philosophy, period-to-period comparisons of our underwriting results may not be meaningful. In addition, our historical investment results may not necessarily be indicative of future performance. Due to the nature of our reinsurance and investment strategies, our operating results will likely fluctuate from period to period.
 
Business outlook
 
The novel coronavirus ("COVID-19") pandemic has had and is expected to continue to have a significant effect on the reinsurance industry. The industry is currently being impacted by a number of factors including: uncertainties with respect to current and future losses, reduction in interest rates, equity market volatility and ongoing business and financial market impacts of an economic downturn. The insurance industry is likely to experience material losses resulting from COVID-19, which will reduce available capital and we expect will help to sustain the upward pricing trend for reinsurers that we were seeing across many lines of business before COVID-19. However, the ultimate impact on current business in force as well as risks and potential opportunities on future business remains highly uncertain.
 
Impact of COVID-19 on Business Operations
 
We reacted quickly and decisively to the COVID-19 crisis when we became aware of the potential impact on our business operations. We have continued to monitor and adjust our operations as the global pandemic unfolds. As local directives required us to transition our operations to remote working arrangements, all functions remained fully operational with all employees having remote access to the Company's network and IT systems. Each employee was equipped with a computer and related equipment at their home to ensure access to our network and efficiency. Prior to the COVID-19 crisis we had general remote, work-from-home capabilities and had previously tested those systems. We have experienced no material disruption in our business operations. As of June 30, 2020, our operations are back to normal. However, should the situation change for the worse, we will revert to working remotely.
 
PRINCIPAL REVENUE AND EXPENSE ITEMS
 
Revenues
 
We derive our most significant revenues from two principal sources:
 
 premiums assumed from reinsurance on property and casualty business; and
 
 income from investments, including Industry Loss Warranties
 
Premiums assumed include all premiums received by a reinsurance company during a specified accounting period, even if the policy provides coverage beyond the end of the period. Premiums are earned over the term of the related policies. At the end of each accounting period, the portion of the premiums that are not yet earned are included in the unearned premiums reserve and are realized as revenue in subsequent periods over the remaining term of the policy. Our policies typically have a term of twelve months. Thus, for example, for a policy that is written on July 1, 2020, typically one-half of the premiums will be earned in 2020 and the other half will be earned during 2021. However, in the event of limit losses on our policies, premium recognition will be accelerated to match losses incurred in the period, when there is no possibility of any future treaty-year losses under the contracts.
 
Premiums from reinsurance on property and casualty business assumed are directly related to the number, type and pricing of contracts we write.
 
Premiums assumed are recorded net of change in loss experience refund, which consists of changes in amounts due to the cedants under one of our reinsurance contracts. These contracts contain retrospective provisions that adjust premiums in the event losses are minimal or zero. We recognize a liability pro-rata over the period in which the absence of loss experience obligates us to refund premiums under the contracts, and we will derecognize such liability in the period in which a loss experience arises. The change in loss experience refund is negatively correlated to loss and loss adjustment expenses described below.
 
 
23
 
 
Income from our investments is primarily comprised of interest income, dividends and net realized and unrealized gains (losses) on investment securities. Such income is primarily from the Company’s investments, which includes investments held in trust accounts that collateralize the reinsurance policies that we write. The investment parameters for trust accounts are generally be established by the cedant for the relevant policy.
 
Industry Loss Warranties 
The Company may buy and sell industry loss warranties as a way to access certain risks. An industry loss warranty is a financial instrument designed to protect insurers or reinsurers from severe losses due to natural and man-made catastrophes and can take the form of either an insurance contract or a swap agreement. Under both forms, a premium is paid at the inception of the contract and, in return, a payout is made if a catastrophic event causes loss to the insurance industry in excess of a predetermined trigger amount.
 
 
Industry loss warranties may also be triggered by other parametric measurements defined in the contract such as observed wind speeds, measured seismic activity or other factors. Industry loss warranties in the form of an insurance contract (also referred to as the "indemnity form") are typically dual-trigger instruments and, in addition to requiring a loss to the industry, require that the buyer of the protection actually suffer a loss from the triggering event. The Company may buy and sell industry loss warranties in the form of an insurance contract or in the form of a derivative contract.
 
Expenses
 
Our expenses consist primarily of the following:
 
 losses and loss adjustment expenses;
 
 policy acquisition costs and underwriting expenses; and
 
 general and administrative expenses.
 
Loss and loss adjustment expenses are a function of the amount and type of reinsurance contracts we write and of the loss experience of the underlying coverage. As described below, loss and loss adjustment expenses are based on the claims reported by our Company’s ceding insurers, and may include an actuarial analysis of the estimated losses, including losses incurred during the period and changes in estimates from prior periods. Depending on the nature of the contract, loss and loss adjustment expenses may be paid over a period of years.
 
Policy acquisition costs and underwriting expenses consist primarily of brokerage fees, ceding commissions, premium taxes and other direct expenses that relate to our writing of reinsurance contracts. We amortize deferred acquisition costs over the related contract term.
 
General and administrative expenses consist of salaries and benefits and related costs, including costs associated with our professional fees, rent and other general operating expenses consistent with operating as a public company.
 
 
24
 
 
RESULTS OF OPERATIONS
 
The following is our consolidated statement of operations and performance ratios for the three and six-month periods ended June 30, 2020 and 2019 (dollars in thousands, except per share amounts):
 
 
 
Three Months Ended
 
 
Six Months Ended
 
 
 
 June 30,
 
 
 June 30,
 
 
 
2020
 
 
2019
 
 
2020
 
 
2019
 
 
 
(unaudited)
 
 
(unaudited)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
 
 
 
 
 
 
 
 
 
 
 
 
Assumed premiums
 $864 
  1,116 
  864 
  1,116 
Change in unearned premiums reserve
  (729)
  (1,023)
  (464)
  (1,023)
 
    
    
    
    
Net premiums earned
  135 
  93 
  400 
  93 
Net investment and other income
  25 
  64 
  57 
  128 
Net realized investment gains
  320 
  - 
  326 
  3 
Change in fair value of equity securities
  2 
  (48)
  (324)
  3 
 
    
    
    
    
Total revenue
  482 
  109 
  459 
  227 
 
    
    
    
    
Expenses
    
    
    
    
Policy acquisition costs and underwriting expenses
  15 
  10 
  44 
  10 
General and administrative expenses
  282 
  280 
  528 
  544 
 
    
    
    
    
Total expenses
  297 
  290 
  572 
  554 
 
    
    
    
    
Income (loss) before income attributable to noteholders
 $185 
  (181)
  (113)
  (327)
 
    
    
    
    
Income attributable to noteholders
  (20)
  (24)
  (86)
  (24)
 
    
    
    
    
Net income (loss)
 $165 
  (205)
  (199)
  (351)
 
    
    
    
    
Earnings (Loss) per share
    
    
    
    
Basic and Diluted
 $0.03 
  (0.04)
  (0.03)
  (0.06)
 
    
    
    
    
 
    
    
    
    
Dividends paid per share
 $- 
  - 
  - 
  -